
Mammoth Biosciencesrevenue, valuation & funding
Brisbane, CaliforniaFounded 2017CEO Trevor Martin
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies and decentralized precision diagnostics.
Mammoth Biosciences revenue
Mammoth Biosciences' annual revenue was $40M in December 2022 (source not recorded), the most recent figure on record.
| As of | Revenue | Source |
|---|---|---|
| Dec 2022 | $40M | – |
– source not recorded
Mammoth Biosciences valuation
Mammoth Biosciences is privately held, so there is no Mammoth Biosciences stock to buy. Investors valued it at $1B in its September 2021 Series D.
Mammoth Biosciences funding rounds & investors
Mammoth Biosciences has raised $332.5M across three rounds since 2018. The latest was a $264.5M Series D in September 2021.
| Date | Round | Raised | Valuation | Source |
|---|---|---|---|---|
| Sep 2021 | Series D | $264.5M | $1B | Business Wire |
| Jan 2020 | Series C | $45M | – | Forbes |
| Jul 2018 | Series A | $23M | – | TechCrunch |
| Total raised | $332.5M |
Mammoth Biosciences CEO, founders & employees
Trevor Martin founded Mammoth Biosciences in 2017 and runs it as CEO. Mammoth Biosciences has 168 employees (November 2025, LinkedIn).
- Trevor MartinCEO/Founder
Mammoth Biosciences FAQ
What is Mammoth Biosciences' revenue?
Mammoth Biosciences' annual revenue was $40M in December 2022 (source not recorded). No later figure is on record.
What is Mammoth Biosciences' valuation?
Investors valued Mammoth Biosciences at $1B in its September 2021 Series D, according to Business Wire.
How much funding has Mammoth Biosciences raised?
Mammoth Biosciences has raised $332.5M across three funding rounds. The latest was a $264.5M Series D in September 2021.
Is Mammoth Biosciences publicly traded?
No. Mammoth Biosciences is a private company, so its shares aren't traded on a stock exchange.
How many employees does Mammoth Biosciences have?
Mammoth Biosciences has 168 employees as of November 2025, according to LinkedIn.
Who is the CEO of Mammoth Biosciences?
Trevor Martin is the CEO of Mammoth Biosciences and founded the company in 2017.
Who founded Mammoth Biosciences?
Trevor Martin founded Mammoth Biosciences in 2017.
Categories
Companies in
How this page is sourced
4 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Nov 24, 2025Data disclaimerReport a correctionClaim this profileRun Mammoth Biosciences? Join the podcast